Abstract
Many herpesviruses express small noncoding RNAs (sncRNAs), including microRNAs (miRNAs), that may play roles in regulating lytic and latent infections. None have yet been reported in varicella-zoster virus (VZV; also known as human herpesvirus 3 [HHV-3]). Here we analyzed next-generation sequencing (NGS) data for small RNAs in VZV-infected fibroblasts and human embryonic stem cell-derived (hESC) neurons. Two independent bioinformatics analyses identified more than 20 VZV-encoded 20- to 24-nucleotide RNAs, some of which are predicted to have stemloop precursors potentially representing miRNAs. These sequences are perfectly conserved between viruses from three clades of VZV. One NGS-identified sequence common to both bioinformatics analyses mapped to the repeat regions of the VZV genome, upstream of the predicted promoter of the immediate early gene open reading frame 63 (ORF63). This miRNA candidate was detected in each of 3 independent biological repetitions of NGS of RNA from fibroblasts and neurons productively infected with VZV using TaqMan quantitative PCR (qPCR). Importantly, transfected synthetic RNA oligonucleotides antagonistic to the miRNA candidate significantly enhanced VZV plaque growth rates. The presence of 6 additional small noncoding RNAs was also verified by TaqMan qPCR in productively infected fibroblasts and ARPE19 cells. Our results show VZV, like other human herpesviruses, encodes several sncRNAs and miRNAs, and some may regulate infection of host cells.
Original language | English |
---|---|
Article number | e01710-17 |
Journal | Journal of Virology |
Volume | 91 |
Issue number | 24 |
DOIs | |
State | Published - 15 Dec 2017 |
Bibliographical note
Publisher Copyright:© 2017 American Society for Microbiology.
Funding
This research was supported by NIH grants R01 AI122640 (P.R.K. and R.G.), R21 NS082662 (P.R.K. and R.G.), US-Israel Bi-National Science Foundation 2013072 (R.G. and P.R.K.). R.G. was also supported by Israel Science Foundation grant 254/16. P.R.K. also acknowledges an NEI CORE grant for Vison Research (EY08098) and unrestricted funds from Research to Prevent Blindness, Inc., and the Eye & Ear Foundation of Pittsburgh. We are very grateful to Noam Shomron (Tel Aviv University) for many helpful discussions that allowed us to pursue this project successfully, as well as reading of an earlier version of the manuscript. We also thank Dena Leshkowitz, Shlomit Gilad, and Sima Benjamin of The Crown Genomics institute of the Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, for expert help and advice. Aryeh Weiss (Bar-Ilan University Faculty of Engineering) provided invaluable advice in the stitching of multiple micrographs. This research was supported by NIH grants R01 AI122640 (P.R.K. and R.G.), R21 NS082662 (P.R.K. and R.G.), US-Israel Bi-National Science Foundation 2013072 (R.G. and P.R.K.). R.G. was also supported by Israel Science Foundation grant 254/16. P.R.K. also acknowledges an NEI CORE grant for Vison Research (EY08098) and unrestricted funds from Research to Prevent Blindness, Inc., and the Eye & Ear Foundation of Pittsburgh
Funders | Funder number |
---|---|
US-Israel bi-national Science Foundation | 2013072 |
National Institutes of Health | R21 NS082662, R01 AI122640 |
National Eye Institute | P30EY008098 |
Eye and Ear Foundation of Pittsburgh | |
Research to Prevent Blindness | |
Israel Science Foundation | 254/16 |
Tel Aviv University |
Keywords
- MicroRNA
- Noncoding RNA
- Varicella-zoster virus